Huihe Medical's K-Clip® Wins 'Advanced Project Award in Consumer and Health Technology' at the 12th CSITF

From June 11 to 13, 2026, the 12th China (Shanghai) International Technology Import and Export Fair (hereinafter referred to as "CSITF") was grandly held at the Shanghai World Expo Exhibition Hall. Amidst this technological feast gathering innovators from 22 countries and regions worldwide and over a thousand innovative enterprises, Shanghai Huihe Healthcare made a prominent debut with its globally first-of-its-kind K-Clip® Transcatheter Tricuspid Annuloplasty System.

K-Clip®Standing out among numerous cutting-edge exhibits with its exceptional technological innovation and clinical value, it won the award at this year’s Shanghai International Trade Fair."Grand Award for Advanced Projects in Consumer Technology and Health Technology", showcasing to the world the robust strength of China's high-end medical devices!

Tricuspid regurgitation is a highly prevalent valvular heart disease, with approximately 16 million patients in China, including up to 5.5 million with severe cases. Traditional open-heart surgery is associated with significant trauma and high risks, leaving many elderly patients or those with multiple comorbidities unable to undergo the procedure.

HuiHe Healthcare's independently developedK-Clip® Transcatheter Tricuspid Annuloplasty System, hailed as the "game changer" in this field. It transforms originally open-chest surgeries into procedures performed via vascular puncture access, offering minimal trauma, rapid recovery, excellent outcomes, and simple operation.Average surgical time is only 30 minutes。

K-Clip® fills the gap in the domestic field of interventional tricuspid valve therapy, becoming the first approved transcatheter product for treating tricuspid regurgitation in China. It also ushers in a new era of global TTVA (Transcatheter Tricuspid Valve Annuloplasty) treatment for tricuspid regurgitation, leading international academic research hotspots. It has successfully treated over 250 patients in China and has been approved to enterSpecial Review “Green Channel” for Innovative Medical Devices

HuiHe HealthcareXu Jun, Chief Technology OfficerIn an interview with the media, it was stated that after this innovative product was approved in China last year, more than 500 surgeries have been completed. It is expected to obtain EU registration certification within this year. One of the purposes of participating in the Shanghai International Medical Device Expo is to increase exposure and seek a broader international market for this "Made in China" innovation.

Awarded at the Shanghai International Technology Fair "Advanced Projects in Consumer Technology and Health Technology" This award is a high recognition of HuiHe Healthcare’s technological innovation and an important milestone for Chinese high-end medical devices going global.

In the future, HuiHe Healthcare will remain true to its original mission, leverage the international platform of the Shanghai International Technology Fair (SITF) to connect with more overseas resources and partners, and enable more patients worldwide to benefit from the health advancements brought by medical technology innovations under "Intelligent Manufacturing in China."